Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AESOPUS: Ultrasound-Adjusted Anticoagulation for DVT
NCT00380120Phase 3Completed
- Sponsor
- Università di Padova
- Start
- Jan 1999
- Primary completion
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of warfarin in deep vein thrombosis (DVT) (2 arms), sponsored by Università di Padova. Primary endpoint: Recurrent Thromboembolism at 33 months. Started Jan 1999; status: completed.
02
Drugs
warfarin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT00380120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00380120.